Acacia Research (Nasdaq: ACTG ) reported earnings on April 18. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Acacia Research crushed expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue shrank significantly. Non-GAAP earnings per share dropped significantly. GAAP earnings per share contracted significantly.
Margins contracted across the board.
Revenue details
Acacia Research logged revenue of $76.9 million. The six analysts polled by S&P Capital IQ hoped for revenue of $55.2 million on the same basis. GAAP reported sales were 22% lower than the prior-year quarter's $99.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Top 10 Performing Companies For 2015: Express Scripts Holding Co (ESRX)
Express Scripts Holding Company, incorporated in 2011, provides healthcare management and administration services on behalf of its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, and government health programs. The Company operates in two segments: Pharmacy Benefit Management (PBM) and Emerging Markets (EM). PBM services include network claims processing, home delivery services, patient care and direct specialty and fertility home delivery to patients, benefit plan design consultation, drug utilization review, formulary management, drug data analysis services, distribution of injectable drugs to patients homes and physicians offices, bio-pharma services, and fulfillment of prescriptions to low-income patients through manufacturer-sponsored patient assistance programs. EM segment provides distribution of pharmaceuticals and medical supplies to providers and clinics, healthcare account administration and implementation of consumer-directed healthcare solutions. In September 2013, it announced the acquisition of the SmartD Medicare Prescription Drug Plan (PDP).
On July 20, 2011, Express Scripts, Inc. (ESI) entered into a merger agreement (the Merger Agreement) with Medco Health Solutions, Inc. (Medco). During the year ended December 31, 2011, it reorganized its FreedomFP line of business from its EM segment into its PBM segment. On April 2, 2012, the Company completed the Merger Agreement, and after which ESI and Medco became the wholly owned subsidiaries of the Company. The Company�� customers include HMOs, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists and others.
Advisors' Opinion:- [By Holly LaFon] ss Scripts is a pharmacy benefit manager that generates revenue through delivering prescription drugs through its network of contracted retail pharmacies, specialty pharmacy services, home delivery and EM services.
Express Scripts��stock tumbled to a 52-week low of $34.37 at the end of the third quarter, from a high of $60.89. Cooperman bought 719,000 shares of the company at an average of $43 per share. He previously owned shares of Express Scripts in 2007 when the price was about $23 per share, and sold over the next several quarters as the stock climbed to $34 in the second quarter of 2008, when he closed his position.
Express Scripts Inc. has a market cap of $24.76 billion; its shares were traded at around $50.17 with a P/E ratio of 17.8 and P/S ratio of 0.5. Express Scripts Inc. had an annual average earnings growth of 28.6% over the past 10 years. GuruFocus rated Express Scripts Inc. the business predictability rank of 5-star.
Over the past decade, Express Scripts has generated strong and growing free cash flow, which grew from $1.6 billion in 2009 to a record of almost $2 billion in 2010.
In October, the company had to lower its earnings per share guidance from the previously expected $3.15 to $3.25, to a range of $2.95 to $3.05. The decrease was due to multiple factors: a greater shortfall in claims versus expectations, a stagnant economy impacting claims volumes, additional expenses, including accelerating spending on projects in preparation for the integration of Medco Health Solutions Inc., expenses to support clients and members as they transfer from Walgreen�� pharmacies and to comply with new regulations. The company is also facing heightened competition.
Later, on October 25, the company announced that it expects 95% of its clients��prescription volume to continue after it loses Walgreens as a network supplier in 2012. It also expects that the merger with Medco, another PBM, will be slightly accretive to EPS in
Best Consumer Service Stocks To Buy For 2014: Rochester Medical Corporation(ROCM)
Rochester Medical Corporation engages in the development, manufacture, and marketing of PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets. Its home care products include a line of silicone and latex male external catheters for managing male urinary incontinence; intermittent catheters for managing both male and female urinary retention, including Magic 3 line of silicone intermittent catheters; and the FemSoft Insert, a soft, liquid-filled, urethral insert for managing stress urinary incontinence in adult females. The company manufactures male external catheters in six models, including UltraFlex, Pop-On, Wide Band, Natural, Clear Advantage, and Transfix catheters; and intermittent catheters in four versions that include standard, antibacterial, hydrophilic, and antibacterial personal catheters. Its acute care products include a line of standard Foley catheters and Strata brand of Foley catheters; and Strata-NF Catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection. The company?s primary customers include distributors, extended care facilities, and individual hospitals and healthcare institutions. It markets its products under the Rochester Medical brand name through a direct sales force in the United States, the United Kingdom, and the Netherlands, as well as through independent distributors in other international markets. The company also supplies its products to various medical product companies for sale under private label brands owned by these companies. Rochester Medical Corporation was founded in 1988 and is headquartered in Stewartville, Minnesota.
Advisors' Opinion:- [By Monica Wolfe]
Gabelli then made two separate buys into Rochester Medical (ROCM). On Sept. 4, the guru upped his stake by over 30% and on Sept. 5, Gabelli added an additional 10.21%. The guru purchased a total of 227,600 shares at an average price of $19.90 per share. Gabelli now holds on to a total of 750,110 shares, representing about 6.12% of the company�� shares outstanding.
Best Consumer Service Stocks To Buy For 2014: Beam Inc (BEAM)
Beam Inc. (Beam), incorporated on October 1, 1985, is a premium spirits company that makes and sells branded distilled spirits products in markets worldwide. The Company's principal products include bourbon whiskey, tequila, Scotch whisky, Canadian whisky, vodka, cognac, rum, cordials, and ready-to-drink pre-mixed cocktails. The Company's portfolio consists of brands the Company identifies as Power Brands, Rising Stars, Local Jewels and values Creators. The Power Brands are the Company's core brand equities, with global reach in premium categories. Rising Stars are smaller premium brands. Brands identified as Local Jewels act as Power Brands in local markets. Value Creators include a variety of brands. The Company's three reportable segments are the geographic regions, which consists of North America, Europe/Middle East/Africa (EMEA), and Asia-Pacific/South America (APSA). Each segment is engaged in the manufacture and sale of distilled spirits products. In May 2012, the Company acquired the Pinnacle vodka and Calico Jack rum brands and certain related assets (Pinnacle assets) from White Rock Distilleries, Inc. In January 2012, Beam acquired Cooley Distillery plc (Cooley), an Irish whiskey producer.
The Company�� Power Brands include Jim Beam Bourbon, Maker's Mark Bourbon, Sauza Tequila, Courvoisier Cognac, Canadian Club Whisky, Teacher's Scotch and Pinnacle Vodka. Beam�� Rising Stars brand includes Laphroaig Scotch, Knob Creek Bourbon, Basil Hayden's Bourbon, Kilbeggan Irish Whiskey, Cruzan Rum, Hornitos Tequila, Skinnygirl Cocktails and Sourz Liqueurs. The principal markets for the Company's spirits products are the United States, Australia, Germany, Spain, the United Kingdom, and Canada, and the Company continues to invest in emerging markets such as India, Brazil, Mexico, Russia, Central Europe, Asia, and other geographies.
During the year ended December 31, 2012, Power Brands, Rising Stars, and combined Local Jewels/Value Creators (including non-branded sales) repre! sent approximately 60%, 15%, and 25%, respectively, of the Company's net sales. Approximately 55% of its consolidated net sales were generated in the United States (based on country of destination) during 2012. In the United States, the Company sells its products either to wholesale distributors for resale to retail outlets or, in those states that control alcohol sales, to state governments who then sell them to retail customers and consumers. In the Company's other global markets, the Company uses a variety of route-to-market models, including third party distributors, global or regional duty free customers, other spirits producers and its joint ventures with The Edrington Group Ltd.
The Company competes with Bacardi Limited, Brown-Forman Corporation, Constellation Brands, Inc., Davide Campari Milano-S.p.A., Diageo PLC, Pernod Ricard S.A. and Remy Cointreau S.A.
Advisors' Opinion:- [By Joseph Gacinga]
Another notable case is the spinoff of Fortune Brands Home & Security (NYSE: FBHS ) from Beam (NYSE: BEAM ) in 2011. Fortune Brands Home & Security shares have climbed at a much faster clip than Beam's shares since then.
- [By Michael Calia]
Activist investor William A. Ackman’s Pershing Square scaled back its stake in Beam Inc.(BEAM) to 8.3%, weeks after the alcoholic-beverage maker agreed to be taken over by Japanese company Suntory. The firm had been the largest shareholder in Beam, with a stake of about 13%.
- [By Jon C. Ogg]
Beam Inc. (NYSE: BEAM) was downgraded to Hold from Buy based on valuation at Argus.
Covidien Ltd. (NYSE: COV) was started as Buy at Needham & Co.
Best Consumer Service Stocks To Buy For 2014: Liberty Property Trust (LRY)
Liberty Property Trust is a publicly owned real estate investment holding trust. Through its subsidiary, it provides leasing, property management, development, acquisition, and other tenant-related services for a portfolio of industrial and office properties. The firm invests in industrial properties including various warehouse, distribution, service, assembly, light manufacturing, and research and development facilities. Its office properties include multi-story and single-story office buildings located principally in suburban mixed-use developments or office parks. Liberty Property Trust was founded in 1972 and is based in Malvern, Pennsylvania.
Advisors' Opinion:- [By Brad Thomas]
Other REITs mentioned: (O), (NNN), (STAG), (DCT), (EGP), (PDM), (DRE), (LRY)
Source: Chambers Street: More Liquidity Magic On The Way In REIT-DomDisclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)
No comments:
Post a Comment